| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.04 |